Published in Thorax on July 01, 1998
Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2002) 4.10
Spinal tuberculosis: a review. J Spinal Cord Med (2011) 2.73
Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax (2007) 2.27
Pulmonary tuberculosis: diagnosis and treatment. BMJ (2006) 2.04
Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection. Thorax (2006) 1.60
Tuberculosis in pregnancy: a review. J Pregnancy (2011) 1.56
Modern laboratory diagnosis of mycobacterial infections. J Clin Pathol (2000) 1.56
Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults. PLoS One (2008) 1.51
Clinical practice: diagnosis of childhood tuberculosis. Eur J Pediatr (2009) 1.50
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat Rev Microbiol (2014) 1.46
Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis. J Clin Microbiol (2001) 1.41
Diagnosing multidrug resistant tuberculosis in Britain. Clinical suspicion should drive rapid diagnosis. BMJ (1998) 1.39
Current difficulties in the diagnosis and management of spinal tuberculosis. Postgrad Med J (2006) 1.39
Challenges in the diagnosis & treatment of miliary tuberculosis. Indian J Med Res (2012) 1.37
Clinical use of anti-TNF therapy and increased risk of infections. Drug Healthc Patient Saf (2013) 1.31
Tuberculous meningitis in Denmark: a review of 50 cases. BMC Infect Dis (2011) 1.26
Etiology and management of genitourinary tuberculosis. Nat Rev Urol (2011) 1.23
Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection. Am J Respir Crit Care Med (2009) 1.21
Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China. PLoS One (2011) 1.18
Tuberculosis verrucosa cutis presenting as diffuse plantar keratoderma: an unusual sight. Indian J Dermatol (2014) 1.18
The challenge of tuberculosis. J R Soc Med (2003) 1.13
Current development and future prospects in chemotherapy of tuberculosis. Respirology (2010) 1.12
A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK. Thorax (2002) 1.11
The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results. J Korean Med Sci (2007) 1.11
Tuberculosis treatment adherence and fatality in Spain. Respir Res (2009) 1.09
The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999 2003. Thorax (2007) 1.05
Mycobacterium tuberculosis and rifampin resistance, United Kingdom. Emerg Infect Dis (2006) 1.02
Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. Indian J Med Res (2013) 1.01
Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management. J Clin Exp Hepatol (2012) 0.99
Multidrug resistance emerging in North London outbreak. Thorax (2006) 0.98
Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid. Antimicrob Agents Chemother (2001) 0.95
Treatment of isoniazid-resistant pulmonary tuberculosis. BMC Infect Dis (2008) 0.95
Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies. Lung India (2012) 0.94
Hepatotoxic effects of therapies for tuberculosis. Nat Rev Gastroenterol Hepatol (2010) 0.92
Monitoring for adverse drug reactions. Br J Clin Pharmacol (2006) 0.91
What happens to people diagnosed with tuberculosis? A population-based cohort. Epidemiol Infect (2007) 0.90
Cost-effectiveness of adding bedaquiline to drug regimens for the treatment of multidrug-resistant tuberculosis in the UK. PLoS One (2015) 0.87
GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis. Eur J Clin Microbiol Infect Dis (2013) 0.86
Therapeutic Trial of Rifabutin After Rifampicin-Associated DRESS Syndrome in Tuberculosis-Human Immunodeficiency Virus Coinfected Patients. Open Forum Infect Dis (2016) 0.85
Clinical review: tuberculosis on the intensive care unit. Crit Care (2013) 0.85
Proposed management of childhood tuberculosis in low-incidence countries. Eur J Pediatr (2008) 0.83
Antituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitis. Lung (2013) 0.82
Medical management of genitourinary tuberculosis. Indian J Urol (2008) 0.81
Wasting among Uganda men with pulmonary tuberculosis is associated with linear regain in lean tissue mass during and after treatment in contrast to women with wasting who regain fat tissue mass: prospective cohort study. BMC Infect Dis (2014) 0.80
A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy. Asia Pac Allergy (2014) 0.80
Periprosthetic tuberculous breast infection. J R Soc Med (2003) 0.80
Isoniazid hepatotoxicity requiring liver transplantation. Dig Dis Sci (2014) 0.80
The role of debridement and reconstruction of sagittal balance in tuberculous spondylitis. Indian J Orthop (2012) 0.79
TB meningitis in HIV-positive patients in Europe and Argentina: clinical outcome and factors associated with mortality. Biomed Res Int (2013) 0.79
Is switching to an oral antibiotic regimen safe after 2 weeks of intravenous treatment for primary bacterial vertebral osteomyelitis? BMC Infect Dis (2014) 0.78
The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide. Clin Interv Aging (2016) 0.78
Active surveillance for tuberculosis in Wales: 1996-2003. Arch Dis Child (2006) 0.78
Use of unlabelled and off licence drugs in children. Use of unlicensed drugs may be recommended in guidelines. BMJ (2000) 0.78
Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries. BMC Health Serv Res (2017) 0.78
More financial resources must be provided for multidrug resistant TB. BMJ (1999) 0.77
Prospective randomized trial of six-month versus nine-month therapy for intestinal tuberculosis. Antimicrob Agents Chemother (2009) 0.77
Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort. PLoS One (2013) 0.76
Current medical treatment for tuberculosis. Resources used for screening could be spent more usefully elsewhere. BMJ (2003) 0.75
An action plan for tuberculosis in England. J R Soc Med (2005) 0.75
Pregnancy does not mean that patients with tuberculosis must stop treatment. BMJ (1999) 0.75
Antitubercular therapy induced liver function tests abnormalities in human immunodeficiency virus infected individuals. Med J Armed Forces India (2017) 0.75
Recurrent Drug-Induced Hepatitis in Tuberculosis-Comparison of Two Drug Regimens. Am J Ther (2015) 0.75
Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK. BMC Infect Dis (2017) 0.75
TB guidelines. Thorax (2000) 0.75
TB screening and anti-TNFalpha treatment. Thorax (2006) 0.75
Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China. BMC Public Health (2012) 0.75
Paradoxical response with increased tumor necrosis factor-α levels to anti-tuberculosis treatment in a patient with disseminated tuberculosis. Respir Med Case Rep (2017) 0.75
Anti-tuberculosis drug-induced hepatitis in renal transplant patient with pulmonary and extra pulmonary tuberculosis. Saudi Pharm J (2011) 0.75
Biphasic Effect of Rifampicin on Bilirubin- A Case Report. J Clin Diagn Res (2016) 0.75
A pain in the foot and a serious complication. J R Soc Med (2007) 0.75
Comparison between titanium mesh and autogenous iliac bone graft to restore vertebral height through posterior approach for the treatment of thoracic and lumbar spinal tuberculosis. PLoS One (2017) 0.75
Miliary tuberculosis: Epidemiologicaland clinical analysis of large-case series from moderate to low tuberculosis endemic Country. Medicine (Baltimore) (2017) 0.75
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet (1993) 16.75
Treatment of multidrug-resistant tuberculosis. N Engl J Med (1993) 7.44
Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc (1970) 5.40
Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med (1993) 5.22
Transmission of tubercle bacilli: The effects of chemotherapy. Tubercle (1976) 4.53
When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis (1993) 3.58
Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis (1986) 3.46
Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ (1982) 3.34
Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med (1995) 3.09
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med (1997) 2.84
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med (1991) 2.77
Control of tuberculosis by community health workers in Bangladesh. Lancet (1997) 2.55
Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet (1995) 2.42
Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle (1977) 2.35
Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis. Am J Respir Crit Care Med (1996) 2.14
Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics (1997) 2.09
Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet (1988) 1.99
Is death inevitable with multiresistant TB plus HIV infection? Lancet (1997) 1.98
Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients: Part 2. Genitourin Med (1997) 1.94
Drug interactions with fluconazole. Rev Infect Dis (1990) 1.87
Directly observed therapy for tuberculosis. BMJ (1996) 1.79
Methadone maintenance and tuberculosis treatment. BMJ (1996) 1.61
Treatment of tuberculosis in HIV infection. Tuber Lung Dis (1992) 1.56
Notification of tuberculosis: an updated code of practice for England and Wales. J R Coll Physicians Lond (1997) 1.52
Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet (1987) 1.49
Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS (1995) 1.48
Hepatotoxicity of antituberculosis drugs. Thorax (1996) 1.46
Lymph node tuberculosis: a comparison of treatments 18 months after completion of chemotherapy. Tubercle (1979) 1.40
Ocular toxicity from ethambutol. Thorax (1986) 1.40
Interaction of ketoconazole with rifampin and isoniazid. N Engl J Med (1984) 1.32
Comprehensive tuberculosis control for patients at high risk for noncompliance. Am J Respir Crit Care Med (1995) 1.31
Extra-pulmonary tuberculosis. Br Med Bull (1988) 1.28
The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis. Am Rev Respir Dis (1986) 1.17
Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study. Chest (1988) 1.14
Directly observed treatment for tuberculosis. Could be provided by community pharmacists supervising consumption of methadone. BMJ (1996) 1.12
A critical evaluation of corticosteroids in tuberculosis. Bibl Tuberc (1966) 1.12
Evaluation of a directly observed six months fully intermittent treatment regimen for tuberculosis in patients suspected of poor compliance. Thorax (1996) 1.10
Molecular diagnosis, detection of drug resistance and epidemiology of tuberculosis. Br J Hosp Med (1997) 1.10
Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients. Genitourin Med (1996) 1.10
Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis. Tubercle (1988) 1.10
Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitis. Br Med J (Clin Res Ed) (1987) 1.09
Corticosteroids in primary tuberculosis with bronchial obstruction. Arch Dis Child (1990) 1.09
Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin. Am Rev Respir Dis (1984) 1.07
Conservative management of renal tuberculosis. Br J Urol (1975) 1.07
The effect of established diabetes mellitus on the presentation of infiltrative pulmonary tuberculosis in the immigrant Asian community of an inner city area of the United Kingdom. Br J Dis Chest (1983) 1.06
Molecular biology in the diagnosis and epidemiology of tuberculosis. J Hosp Infect (1994) 1.06
The third epidemic--multidrug-resistant tuberculosis. Chest (1994) 1.02
Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results. Respir Med (1993) 1.02
Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis. Arch Dis Child (1998) 0.99
Treatment of tuberculosis. The Mitchell lecture 1979. J R Coll Physicians Lond (1980) 0.97
The management of pulmonary tuberculosis notified in England and Wales in 1993. J R Coll Physicians Lond (1998) 0.96
Rifampin preventive therapy for tuberculosis in Boston's homeless. Am J Respir Crit Care Med (1996) 0.94
Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis. Am J Respir Crit Care Med (1996) 0.92
United States Public Health Service Tuberculosis Therapy Trial 21: preliminary results of an evaluation of a combination tablet of isoniazid, rifampin and pyrazinamide. Tubercle (1987) 0.89
Tuberculosis in children: an update. Pediatr Pulmonol (1996) 0.89
Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature. Int J Tuberc Lung Dis (1997) 0.88
Childhood tuberculosis. Adv Pediatr Infect Dis (1993) 0.85
The management of tuberculous meningitis. Thorax (1992) 0.84
The downside of isoniazid chemoprophylaxis. Lancet (1995) 0.84
Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels. Indian Pediatr (1996) 0.82
The management of lymph node tuberculosis notified in England and Wales in 1993. J R Coll Physicians Lond (1998) 0.81
The ultimate decision analysis: the confirmation of reality through theory. Am J Respir Crit Care Med (1996) 0.81